Nucleosides

2'-Modified Nucleosides
(288/288)
3'-Modified Nucleosides
(157/157)
5'-Modified Nucleosides
(236/236)
Anhydro-Nucleosides
(13/13)
Arabinonucleosides
(34/34)
Base Protected Nucleosides
(224/224)
Halogen Nucleosides
(134/134)
L-Nucleosides
(18/18)
Other Nucleosides
(77/77)
Other Protected Nucleosides
(23/23)
Ribonucleosides
(11/11)
Backbone
Modification
Base Type
Filtered by
Clear All

2',3'-Ipr-Ino

Description: 2',3'-Ipr-Ino, an extraordinary biomedicine, exhibits profound efficacy in combating specific diseases. Renowned for its ability to combat RNA viruses, it has undergone comprehensive scrutiny and has consistently illustrated remarkable potential in suppressing the replication of diverse RNA viruses.
CAT: BRP-00186
CAS: 2140-11-6
MF: C13H16N4O6
MF: 308.29
Purity: 98%
Appearance: White Crystal Powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8°C
Density: 1.80±0.1 g/cm3
Melting Point: 263-272°C
Boiling Point: 606.6±65.0 °C at 760 mmHg
InChIKey: LIEKLUBCIPVWQD-WOUKDFQISA-N
CanonicalSMILES: CC1(OC2C(OC(C2O1)N3C=NC4=C3N=CNC4=O)CO)C
IUPAC Name: 9-[(3aR,4R,6R,6aR)-6-(hydroxymethyl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]-1H-purin-6-one
InChI: InChI=1S/C13H16N4O5/c1-13(2)21-8-6(3-18)20-12(9(8)22-13)17-5-16-7-10(17)14-4-15-11(7)19/h4-6,8-9,12,18H,3H2,1-2H3,(H,14,15,19)/t6-,8-,9-,12-/m1/s1
Synonyms: 2',3'-O-Isopropylideneinosine; 2',3'-Isopropylideneinosine; 2',3'-o-(1-methylethylidene)inosine

2',3'-O-Isopropylideneguanosine

Description: 2',3'-O-Isopropylideneguanosine is a modified nucleoside derivative of guanosine. It has an isopropylidene group attached at the 2' and 3' positions of the ribose ring. This modification can enhance the stability and bioavailability of the nucleoside, making it useful in pharmaceutical and biochemical research.
CAT: BRP-00187
CAS: 362-76-5
MF: C13H17N5O5
MF: 323.31
Purity: 98%
Appearance: White to Off-White Solid
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8°C (under dark)
Density: 1.93 g/cm3
Melting Point: 296 °C
Boiling Point: 647°C at 760 mmHg
InChIKey: XKPDAYWPKILAMO-IOSLPCCCSA-N
Solubility: Soluble in DMSO, Ethanol, Methanol
CanonicalSMILES: CC1(OC2C(OC(C2O1)N3C=NC4=C3N=C(NC4=O)N)CO)C
IUPAC Name: 9-[(3aR,4R,6R,6aR)-6-(hydroxymethyl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]-2-amino-1H-purin-6-one
InChI: InChI=1S/C13H17N5O5/c1-13(2)22-7-5(3-19)21-11(8(7)23-13)18-4-15-6-9(18)16-12(14)17-10(6)20/h4-5,7-8,11,19H,3H2,1-2H3,(H3,14,16,17,20)/t5-,7-,8-,11-/m1/s1
Synonyms: 2',3'-O-(1-Methylethylidene)guanosine; Guanosine, 2',3'-O-isopropylidene-; 2',3'-Isopropylideneguanosine; Isopropylideneguanosine; 2-Amino-9-((3aR,4R,6R,6aR)-6-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)-1H-purin-6(9H)-one; 9-[(3aR,4R,6R,6aR)-6-(hydroxymethyl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]-2-amino-3H-purin-6-one

2',3'-Di-O-isopropylidene adenosine

Description: It is used for special nucleoside.
CAT: BRP-00188
CAS: 362-75-4
MF: C13H17N5O4
MF: 307.31
Purity: ≥95%
Appearance: White to off-white solid
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C
Density: 1.8±0.1 g/cm3
Melting Point: >214 °C (dec.)
Boiling Point: 570.5±60.0 °C at 760 mmHg
InChIKey: LCCLUOXEZAHUNS-UHFFFAOYSA-N
Solubility: Soluble in Dioxane (Slightly, Sonicated), DMSO (Slightly), Methanol (Slightly)
CanonicalSMILES: CC1(OC2C(OC(C2O1)N3C=NC4=C3N=CN=C4N)CO)C
IUPAC Name: [(3aR,4R,6R,6aR)-4-(6-aminopurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methanol
InChI: InChI=1S/C13H17N5O4/c1-13(2)21-8-6(3-19)20-12(9(8)22-13)18-5-17-7-10(14)15-4-16-11(7)18/h4-6,8-9,12,19H,3H2,1-2H3,(H2,14,15,16)
Synonyms: 2',3'-O-(1-Methylethylidene)adenosine; NSC 29413; [(1R,2R,4R,5R)-4-(6-aminopurin-9-yl)-7,7-dimethyl-3,6,8-trioxabicyclo[3.3.0]oct-2-yl]methan-1-ol

Isoprinosine

Description: Isoprinosine is a complex of acetaminobenzoic acid, dimethylaminoisopropanol, and inosine with the ratio of 3:3:1. It is an immunomodulatory drug approved in several countries for the treatment of viral infections.
CAT: BRP-00189
CAS: 36703-88-5
MF: C10H12N4O5.3C9H9NO3.3C5H13NO
MF: 1115.23
Purity: ≥98% by HPLC
Appearance: White or almost white crystalline powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store in a cool and dry place and at 2-8 °C for short term (days to weeks) or -20 °C for long term (months to years)
Flash Point: 397°C
InChIKey: YLDCUKJMEKGGFI-QCSRICIXSA-N
Solubility: Soluble in DMSO
CanonicalSMILES: CC(CN(C)C)O.CC(CN(C)C)O.CC(CN(C)C)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.CC(=O)NC1=CC=C(C=C1)C(=O)O.C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)CO)O)O
IUPAC Name: 4-acetamidobenzoic acid;9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one;1-(dimethylamino)propan-2-ol
InChI: InChI=1S/C10H12N4O5.3C9H9NO3.3C5H13NO/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18;3*1-6(11)10-8-4-2-7(3-5-8)9(12)13;3*1-5(7)4-6(2)3/h2-4,6-7,10,15-17H,1H2,(H,11,12,18);3*2-5H,1H3,(H,10,11)(H,12,13);3*5,7H,4H2,1-3H3/t4-,6-,7-,10-;;;;;;/m1....../s1
Synonyms: Inosine, compd. with 1-(dimethylamino)-2-propanol 4-(acetylamino)benzoate (1:3:3); Inosine, compd. with 1-(dimethylamino)-2-propanol 4-(acetylamino)benzoate (salt) (1:3); Aviral; Delimmun; Groprinosin; Immunovir; Imunovir; Inosine acedobene dimepranol; Inosine pranobex; Inosiplex; Isoprinosin; Methisoprinol; Metyzoprynol; Modimmunal; NP 113; NPT 10381; Pranosina; Pranosine; Viruxan

Inosine

Description: Inosine is a nucleoside that is formed when hypoxanthine is attached to a ribose ring (also known as a ribofuranose) via a β-N9-glycosidic bond.
CAT: BRP-00191
CAS: 58-63-9
MF: C10H12N4O5
MF: 268.23
Purity: ≥98% by HPLC
Appearance: White Crystalline Powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20°C
Density: 2.1±0.1 g/cm3
Melting Point: 207-210°C
Boiling Point: 670.5±65.0°C at 760 mmHg
Flash Point: 397°C
Application: coenzymes
Symbol: I
InChIKey: UGQMRVRMYYASKQ-KQYNXXCUSA-N
Solubility: Soluble in DMSO (Slightly), Methanol (Slightly), Water (Slightly)
CanonicalSMILES: C1=NC(=O)C2=C(N1)N(C=N2)C3C(C(C(O3)CO)O)O
IUPAC Name: 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
InChI: InChI=1S/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m1/s1
Synonyms: 1,9-Dihydro-9-β-D-ribofuranosyl-6H-purin-6-one; 9-β-D-Ribofuranosylhypoxanthine; Hypoxanthine 9-β-D-ribofuranoside; Hypoxanthine Ribonucleoside; Hypoxanthine Riboside; Hypoxanthosine; Ribonosine; Atorel; Oxiamin; Trophicardyl; Selfer; ribo Inosine; HXR; Ino; Inosie; NSC 20262

2'-O-Methyl-5-methyluridine

Description: 2'-O-Methyl-5-methyluridine is a nucleoside analogue used in the development of antiviral drugs and anticancer agents. It has shown inhibitory activity against hepatitis C virus (HCV) and respiratory syncytial virus (RSV). It also acts as a potential target for cancer therapy due to its involvement in the regulation of cell growth and proliferation.
CAT: BRP-00192
CAS: 55486-09-4
MF: C11H16N2O6
MF: 272.26
Purity: ≥95%
Appearance: White to Off-white Solid
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20°C under inert atmosphere
Density: 1.47±0.1 g/cm3 (Predicted)
Melting Point: 183-186°C
Symbol: m5Um
InChIKey: YHRRPHCORALGKQ-FDDDBJFASA-N
Solubility: Soluble in DMSO (Slightly), Methanol (Slightly, Sonicated)
CanonicalSMILES: CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)OC
IUPAC Name: 1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione
InChI: InChI=1S/C11H16N2O6/c1-5-3-13(11(17)12-9(5)16)10-8(18-2)7(15)6(4-14)19-10/h3,6-8,10,14-15H,4H2,1-2H3,(H,12,16,17)/t6-,7-,8-,10-/m1/s1
Synonyms: 5-Methyl-2'-O-methyluridine; 2'-O-Methylribothymidine; 1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione; 5,2'-O-Dimethyluridine; 1-(2-O-Methyl-beta-D-ribofuranosyl)thymine

5-Methyluridine

Description: 5-Methyl-uridine is an urinary nucleoside used as biological marker for the treatment of colorectal cancer. It is also a primary degradation product of tRNA.
CAT: BRP-00193
CAS: 1463-10-1
MF: C10H14N2O6
MF: 258.23
Purity: ≥95%
Appearance: White to Off-white Solid
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20°C
Density: 1.576±0.06 g/cm3 (Predicted)
Melting Point: 183-185°C
Symbol: m5U
InChIKey: DWRXFEITVBNRMK-JXOAFFINSA-N
Solubility: Soluble in Methanol (Slightly, Heated, Sonicated), Water (Sparingly, Sonicated)
CanonicalSMILES: CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O
IUPAC Name: 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
InChI: InChI=1S/C10H14N2O6/c1-4-2-12(10(17)11-8(4)16)9-7(15)6(14)5(3-13)18-9/h2,5-7,9,13-15H,3H2,1H3,(H,11,16,17)/t5-,6-,7-,9-/m1/s1
Synonyms: Uridine, 5-methyl-; Ribothymidine; Thymine riboside; 1-β-D-Ribofuranosylthymine; 5-Methyl-1-β-D-ribofuranosyl-2,4(1H,3H)-pyrimidinedione; 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione

Spongouridine

Description: 1-β-D-Arabinofuranosyluracil is an antiviral agent. It is used for the treatment of severe acute respiratory syndrome (SARS). It is also an impurity of Cytarabine.
CAT: BRP-00194
CAS: 3083-77-0
MF: C9H12N2O6
MF: 244.20
Purity: ≥95%
Appearance: White to Off-white Powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20°C
Density: 1.674±0.06 g/cm3 (Predicted)
Melting Point: 220-222°C
InChIKey: DRTQHJPVMGBUCF-CCXZUQQUSA-N
Solubility: Soluble in Methanol (Slightly), Water (Slightly)
CanonicalSMILES: C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O
IUPAC Name: 1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C9H12N2O6/c12-3-4-6(14)7(15)8(17-4)11-2-1-5(13)10-9(11)16/h1-2,4,6-8,12,14-15H,3H2,(H,10,13,16)/t4-,6-,7+,8-/m1/s1
Synonyms: Arauridine; 1-(β-D-Arabinofuranosyl)uracil; Uracil-1-β-D-arabinofuranoside; 1-β-D-Arabinofuranosyl-2,4(1H,3H)-pyrimidinedione; Ara-U; Arabinosyluracil; NSC 68928; Uracil Arabinoside; Cytarabine Impurity A; Cytarabine EP Impurity A; 1-β-D-arabinofuranosylpyrimidine-2,4(1H,3H)-dione

Guanosine

Description: Guanosine is a purine nucleoside comprising guanine attached to a ribose (ribofuranose) ring via a β-N9-glycosidic bond.
CAT: BRP-00196
CAS: 118-00-3
MF: C10H13N5O5
MF: 283.24
Purity: ≥95%
Appearance: White to Light Yellow Powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8°C (under dark)
Density: 2.25±0.1 g/cm3
Melting Point: 239°C (dec.)
Boiling Point: 775.9±70.0°C at 760 mmHg
Flash Point: 423.1°C
InChIKey: NYHBQMYGNKIUIF-UUOKFMHZSA-N
Solubility: Soluble in Water
CanonicalSMILES: C1=NC2=C(N1C3C(C(C(O3)CO)O)O)NC(=NC2=O)N
IUPAC Name: 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
InChI: InChI=1S/C10H13N5O5/c11-10-13-7-4(8(19)14-10)12-2-15(7)9-6(18)5(17)3(1-16)20-9/h2-3,5-6,9,16-18H,1H2,(H3,11,13,14,19)/t3-,5-,6-,9-/m1/s1
Synonyms: 2-Amino-1,9-dihydro-9-β-D-ribofuranosyl-6H-purin-6-one; 6H-Purin-6-one, 2-amino-1,9-dihydro-9-β-D-ribofuranosyl-; DL-Guanosine; Guanine ribonucleoside; Guanine, 9-β-D-ribofuranosyl-; Inosine, 2-amino-; NSC 19994; Vernine; β-D-Ribofuranoside, guanine-9; ribo Guanosine
Related CAS: 141433-61-6 (hydrate) ; 85-30-3 (Deleted CAS) ; 484-80-0 (Deleted CAS) ; 685891-87-6 (Deleted CAS) ; 1022900-70-4 (Deleted CAS)

Cytarabine hydrochloride

Description: Cytarabine, an antimetabolite analogue of cytidine with a modified sugar moiety, is an antimetabolic agent and DNA synthesis inhibitor.
CAT: BRP-00197
CAS: 69-74-9
MF: C9H14ClN3O5
MF: 279.68
Purity: 95%
Appearance: White powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
Melting Point: 197-198 °C
Boiling Point: 545.7°C at 760 mmHg
Flash Point: 283.8°C
Shelf Life: As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
InChIKey: KCURWTAZOZXKSJ-JBMRGDGGSA-N
Solubility: Soluble in DMSO
CanonicalSMILES: C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O.Cl
IUPAC Name: 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;hydrochloride
InChI: 1S/C9H13N3O5.ClH/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8;/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16);1H/t4-,6-,7+,8-;/m1./s1
Synonyms: Cytosine arabinoside hydrochloride; 1-beta-D-Arabinofuranosylcytosine hydrochloride; Aracytidine hydrochloride; 4-Amino-1-β-D-arabinofuranosyl-2(1H)-pyrimidinone hydrochloride; Arabinocytidine hydrochloride; Arabinofuranosylcytosine hydrochloride
Related CAS: 147-94-4 (free base)

2',3',5'-triacetyl-5-azacytidine

Description: 5-Azacytidine is an inhibitor of DNA methyltransferase, potentially serving to reverse epigenetic changes. 2',3',5'-triacetyl-5-Azacytidine is a prodrug form of 5-azacytidine.
CAT: BRP-00198
CAS: 10302-78-0
MF: C14H18N4O8
MF: 370.31
Purity: ≥98% by HPLC
Appearance: Crystalline Solid
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8°C
Density: 1.60±0.1 g/cm3 (Predicted)
Boiling Point: 497.3±55.0 °C at 760 mmHg
InChIKey: OTQJVHISAFFLMA-DDHJBXDOSA-N
Solubility: Soluble in DMF (30 mg/ml), DMSO (30 mg/ml), Ethanol (30 mg/ml), PBS (pH 7.2, 10 mg/ml)
CanonicalSMILES: CC(=O)OCC1C(C(C(O1)N2C=NC(=NC2=O)N)OC(=O)C)OC(=O)C
IUPAC Name: [(2R,3R,4R,5R)-3,4-diacetyloxy-5-(4-amino-2-oxo-1,3,5-triazin-1-yl)oxolan-2-yl]methyl acetate
InChI: InChI=1S/C14H18N4O8/c1-6(19)23-4-9-10(24-7(2)20)11(25-8(3)21)12(26-9)18-5-16-13(15)17-14(18)22/h5,9-12H,4H2,1-3H3,(H2,15,17,22)/t9-,10-,11-,12-/m1/s1
Synonyms: 5-Azacytidine 2',3',5'-O-triacetate; 2',3',5'-Triacetate-4-amino-1-β-D-ribofuranosyl-s-triazin-2(1H)-one; 2',3',5'-Tri-O-acetyl-5-Azacitidine; NSC 291930; 4-Amino-1-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one

Cytarabine

Description: Arabinofuranosyl-cytosine (ara-C) is an inhibitor of DNA synthesis used as an antineoplastic and antiviral. It is a chemotherapy agent used to treat cancers of white blood cells like acute myeloid leukemia (AML) and non-Hodgkin lymphoma.
CAT: BRP-00199
CAS: 147-94-4
MF: C9H13N3O5
MF: 243.22
Purity: ≥95%
Appearance: Solid
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20°C
Density: 1.89±0.1 g/cm3
Melting Point: >210°C (dec.)
Boiling Point: 545.7±60.0°C at 760 mmHg
Application: Arabinofuranosyl-cytosine (ara-C) is an inhibitor of DNA synthesis.
InChIKey: UHDGCWIWMRVCDJ-CCXZUQQUSA-N
Solubility: Soluble in DMSO (Slightly, Heated), Ethanol (Slightly), Methanol (Slightly, Heated), Water
CanonicalSMILES: O=C1N=C(C=CN1[C@H]2[C@@H](O)[C@H](O)[C@@H](CO)O2)N
IUPAC Name: 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
InChI: InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1
Synonyms: cytarabine;147-94-4;Ara-C;Cytosine arabinoside;Aracytidine;Arabinocytidine;Cytarabinoside;Spongocytidine;Aracytin;Cytosar-U;Depocyt;Udicil;Arabinofuranosylcytosine;Arabitin;Aracytine;Cytarabina;Tarabine;Arafcyt;Erpalfa;1-beta-D-Arabinofuranosylcytosine;arabinocytosine;Cytarabinum;Cytosine beta-D-arabinofuranoside;DepoCyte;Arabinosylcytosine;Cytarabin;Cytosar;Cytosinearabinoside;Citarabina;Depocyt (liposomal);beta-D-Arabinosylcytosine;Cytosine arabinofuranoside;Alexan;Cytosine beta-D-arabinoside;Cytarabinum [INN-Latin];Arabinoside C;1beta-D-Arabinosylcytosine;4-Amino-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one;Citarabina [INN-Spanish];Cytosine-1-beta-D-arabinofuranoside;AraC;Cytosine arabinose;4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone;1beta-Arabinofuranasylcytosine;Iretin;Cytosine 1-beta-D-arabinofuranoside;1beta-D-Arabinofuranosylcytosine;1-beta-D-Arabinofaranosylcytosine;beta-Arabinosylcytosine;Ara-Cytidine;U 19920A;Beta-cytosine arabinoside;Cytosine-beta-arabinoside;Cytosine-beta-D-arabinofuranoside;cytarabine liposome;1-Arabinofuranosylcytosine;CHX 3311;CCRIS 913;U-19,920;4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one;Arabinofuranosyl Cytidine;Cytosine, 1-beta-D-arabinosyl-;1-beta-D-Arabinosylcytosine;HSDB 3049;1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone;EINECS 205-705-9;1-(arabinofuranosyl)cytosine;Cyclocide;Cytosine, 1-beta-D-arabinofuranosyl-;NSC 287459;UNII-04079A1RDZ;1-beta-arabinofuranosylcytosine;U-19920;Cytosine |A-D-Arabinofuranoside;DTXSID3022877;CHEBI:28680;AI3-52329;(beta-D-Arabinofuranosyl)cytosine;4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin;04079A1RDZ;2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl-;MFCD00066487;CHEMBL803;NSC-287459;MK 8242;4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon;4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one;C9H13N3O5;DTXCID702877;2(1H)-Pyrimidinone, 4-amino-1-.beta.-D-arabinofuranosyl-;AR3;Cytonal;NCI-C04728;VYXEOS COMPONENT CYTARABINE;1-beta-D-arabinofuranosyl-cytosine;4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine;AC-1075;beta-Ara C;Cytarabine [USAN:USP:INN:BAN:JAN];NCGC00093356-03;2(1H)-Pyrimidinone, 4-amino-1-y-D-arabinofuranosyl- [CAS];Cytarbel;(Arabinofuranosyl)cytosine;Cytarabinum (INN-Latin);Citarabina (INN-Spanish);CYTARABINE (MART.);CYTARABINE [MART.];CYTARABINE (USP-RS);CYTARABINE [USP-RS];Citozar;ara-Cytosine;Cytosine arabinoside (VAN);Tarabine PFS;CYTARABINE (EP MONOGRAPH);CYTARABINE (USP IMPURITY);CYTARABINE [EP MONOGRAPH];CYTARABINE [USP IMPURITY];Cytosine-1-beta-arabinofuranoside;CYTARABINE (USP MONOGRAPH);CYTARABINE [USP MONOGRAPH];Ara-cell;Cytarabine (USAN:USP:INN:BAN:JAN);cytarabine liposome injection;Arabinosyl Cytosine;Cytosine, beta-D-arabinoside;CAS-147-94-4;SMR000449317;Depocyt (TN);Arabinoside, Cytosine;4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;Cytartbine;Arabine;1-.beta.-D-Arabinofuranosylcytosine;Cytarabine; 4-amino-1-beta-d-arabinofuranosylpyrimidin-2(1H)-one;SR-01000075773;NSC287459;4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech];4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech];1-(beta-d-arabinofuranosyl)cytosine;1-.beta.-D-arabinofuranosyl-cytosine;4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone;U-19920 A;cytarabine ocphosphate;1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside;beta -arabinosylcytosine;Arabinofuranosylcytosine?;CYTARABINE [MI];U 19920;CYTARABINE [INN];CYTARABINE [JAN];CYTARABINE [HSDB];CYTARABINE [USAN];beta -cytosine arabinoside;beta -D-arabinosylcytosine;Cytosine-beta -arabinoside;CYTARABINE [VANDF];SCHEMBL3140;1beta -D-Arabinosylcytosine;CYTARABINE [WHO-DD];CYTARABINE [WHO-IP];BIDD:PXR0139;Lopac0_000316;MLS000758310;MLS001066340;MLS001424023;1-beta-D-Arabinosyl-Cytosine;BIDD:GT0371;CYTARABINE [EMA EPAR];Cytosine, beta -D-arabinoside;1beta -Arabinofuranasylcytosine;Cytarabine (JP18/USP/INN);GTPL4827;1-ss-D-Arabinofuranosylcytosine;2(1H)-Pyrimidinone, 4-amino-1beta-D-arabinofuranosyl-;CYTARABINE [ORANGE BOOK];SCHEMBL22591193;SCHEMBL23152019;1beta -D-Arabinofuranosylcytosine;BETA-CYTOSINE, ARABINOSIDE;L01BC01;Cytosine, 1-beta -D-arabinosyl-;1-beta -d-arabinofuranosylcytosine;1-beta-D-arabinofuranosyl cytosine;Cytosine-beta -D-arabinofuranoside;HMS2051K19;HMS2090A18;HMS2230M16;HMS3713N12;1-beta -D-Arabinofaranosylcytosine;CYTARABINE LIPOSOME [VANDF];CYTARABINUM [WHO-IP LATIN];BCP02876;Tox21_111203;Tox21_301971;BDBM50087289;CCG-51297;s1648;AKOS007930145;AKOS015896896;AM84428;Cytosine, 1-beta -D-arabinofuranosyl-;DB00987;KS-5063;NC00070;SDCCGSBI-0050304.P002;NCGC00093356-04;NCGC00093356-05;NCGC00093356-06;NCGC00093356-19;NCGC00142483-02;NCGC00255381-01;1(BETA-D-ARABINOFURANOSYL)CYTOSINE;BA164339;HY-13605;SRI-10828-19;SRI-10828-20;SRI-10828_24;WR-28453;SL-000002;U 19,920A;C2035;NS00005949;SW197450-5;C02961;D00168;EN300-118320;1-BETA-D-ARABINOFURANOSYLCYTOSINE; ARA-C;A808710;Q180983;SR-01000721860;J-520199;J-700005;J-700166;SR-01000075773-3;SR-01000075773-5;SR-01000721860-6;U 19,920;1-beta -D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone;2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl;BRD-K33106058-001-07-7;BRD-K33106058-001-16-8;BRD-K33106058-003-20-6;1-BETA-D-ARABINOSYL-4-AMINO-2(1H)PYRIMIDINONE;2(1H)-Pyrimidinone, 4-amino-1beta -D-arabinofuranosyl-;Cytosine -D-arabinofuranoside;Cytosine Arabinoside;Ara-C;Z1511499171;2(1H)-Pyrimidinone, 4-amino-1-beta -D-arabinofuranosyl-;Cytarabine, European Pharmacopoeia (EP) Reference Standard;Cytarabine, United States Pharmacopeia (USP) Reference Standard;Cytosine beta-D-arabinofuranoside, crystalline, >=90% (HPLC);Cytosine beta-D-arabinofuranoside, Vetec(TM) reagent grade, 90%;Cytarabine, Pharmaceutical Secondary Standard; Certified Reference Material;4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one;Cytosine -D-arabinofuranoside hydrochloride;Cytosine Arabinoside hydrochloride;Ara-C hydrochloride;
Related CAS: 69-74-9 ; (hydrochloride)

Cytidine

Description: Cytidine is a nucleoside molecule that is formed when cytosine is attached to a ribose ring, cytidine is a component of RNA.
CAT: BRP-00200
CAS: 65-46-3
MF: C9H13N3O5
MF: 243.22
Purity: ≥98% by HPLC
Appearance: white crystalline powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8°C
Density: 1.89±0.1 g/cm3
Melting Point: 230.5 °C (dec.)
Boiling Point: 545.7±60.0 °C at 760 mmHg
Flash Point: 283.8°C
InChIKey: UHDGCWIWMRVCDJ-XVFCMESISA-N
Solubility: Soluble in water
CanonicalSMILES: C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O
IUPAC Name: 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
InChI: InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7-,8-/m1/s1
Synonyms: Cytosine riboside; MK-0431; MK 0431; MK0431; ribo Cytidine; 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-(amino)pyrimidin-2(1H)-one; 1-(β-D-Ribofuranosyl)-2-oxo-4-amino-1,2-dihydro-1,3-diazine; 1-β-D-Ribofuranosylcytosine; 4-Amino-1-β-D-ribofuranosyl-2(1H)-pyrimidinone; NSC 20258; β-D-Cytidine; β-D-Ribofuranoside, cytosine-1

2-Iodoadenosine

Description: An intermediate in the synthesis of isoguanosine (crotonoside or 2-hydroxyadenosine), a naturally occuring nucleoside analogue of guanosine. Isoguanosine is incorporated into mammalian but not bacterial nucleic acids, stimulates the accumulation of cyclic AMP in the brain, and is an inhibitor of IMP (pyrophosphorylase).
CAT: BRP-00201
CAS: 35109-88-7
MF: C10H12IN5O4
MF: 393.14
Purity: ≥95%
Appearance: Off-White to Pale Yellow Solid
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8°C under inert atmosphere
Density: 2.69±0.1 g/cm3 (Predicted)
Melting Point: >190°C (dec.)
Boiling Point: 776.3±70.0°C (Predicted)
InChIKey: MGEBVSZZNFOIRB-UUOKFMHZSA-N
Solubility: Soluble in DMSO, Hot Methanol, Water
CanonicalSMILES: C1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(N=C2N)I
IUPAC Name: (2R,3R,4S,5R)-2-(6-amino-2-iodopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
InChI: InChI=1S/C10H12IN5O4/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)/t3-,5-,6-,9-/m1/s1
Synonyms: 2-Iodo Adenosine; 6-Amino-2-iodo-9-(beta-D-ribofuranosyl)purine; (2R,3R,4S,5R)-2-(6-amino-2-iodo-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

5'-Tosyl Adenosine

Description: 5'-Tosyl Adenosine is a chemically modified adenosine nucleotide in which the 5'-hydroxyl group of adenosine is substituted with a tosyl (p-toluenesulfonyl) group. This modification makes it a useful intermediate in organic synthesis and nucleoside chemistry. The tosyl group acts as a leaving group, facilitating various chemical reactions, such as nucleophilic substitutions, that can introduce other functional groups at the 5' position of adenosine. 5'-Tosyl Adenosine is often utilized in the preparation of modified nucleotides for research in biochemistry and molecular biology.
CAT: BRP-00202
CAS: 5135-30-8
MF: C17H19N5O6S
MF: 421.43
Purity: ≥95%
Appearance: White to off-white solid
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C (under dark)
Density: 1.8±0.1 g/cm3
Melting Point: 151 °C
Boiling Point: 760.1±70.0 °C at 760 mmHg
InChIKey: CAXLRAROZXYOHH-LSCFUAHRSA-N
Solubility: Soluble in DMSO (Slightly), Methanol (Slightly, Heated)
CanonicalSMILES: CC1=CC=C(C=C1)S(=O)(=O)OCC2C(C(C(O2)N3C=NC4=C3N=CN=C4N)O)O
IUPAC Name: [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl 4-methylbenzenesulfonate
InChI: InChI=1S/C17H19N5O6S/c1-9-2-4-10(5-3-9)29(25,26)27-6-11-13(23)14(24)17(28-11)22-8-21-12-15(18)19-7-20-16(12)22/h2-5,7-8,11,13-14,17,23-24H,6H2,1H3,(H2,18,19,20)/t11-,13-,14-,17-/m1/s1
Synonyms: Adenosine 5'-(4-Methylbenzenesulfonate); 5'-O-Toluenesulfonyladenosine; 5'-Tosyladenosine

2-Chloroadenosine

Description: 2-Chloroadenosine is a nucleoside antibiotic produced by Streptomyces rishiensis. It has anti-gram-positive and negative bacteria activity.
CAT: BRP-00203
CAS: 146-77-0
MF: C10H12ClN5O4
MF: 301.69
Purity: ≥95%
Appearance: White to Off-white Solid
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20°C
Density: 2.19 g/cm3
Melting Point: 133-136 °C (dec.)
Boiling Point: 591.8°C at 760 mmHg
InChIKey: BIXYYZIIJIXVFW-UUOKFMHZSA-N
Solubility: Soluble in DMSO (Slightly), Methanol (Slightly, Heated, Sonicated)
CanonicalSMILES: C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)Cl)N
IUPAC Name: (2R,3R,4S,5R)-2-(6-amino-2-chloropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
InChI: InChI=1S/C10H12ClN5O4/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)/t3-,5-,6-,9-/m1/s1
Synonyms: AT-265-B; AT-265B; 6-Amino-2-chloropurine riboside; (2R,3R,4S,5R)-2-(6-amino-2-chloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; 2-Chloro-9-(beta-D-ribofuranosyl)adenine; 2-Chlor-9-(β-D-ribofuranosyl)-9H-purin-6-amine; 2'-Chloroadenosine
Related CAS: 81012-94-4 (hemihydrate)

2-Aminoadenosine

Description: It is a nucleoside analogue as an inhibitor or substrate of adenosine kinase from M. tuberculosis.
CAT: BRP-00204
CAS: 2096-10-8
MF: C10H14N6O4
MF: 282.26
Purity: ≥95%
Appearance: White to off-white solid
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at 2-8 °C
Density: 2.25±0.1 g/cm3 (Predicted)
Melting Point: 241-243 °C (dec.)
Boiling Point: 798.5±70.0 °C at 760 mmHg
InChIKey: ZDTFMPXQUSBYRL-UUOKFMHZSA-N
Solubility: Soluble in Aqueous Acid (Slightly, Heated, Sonicated), DMSO (Slightly, Sonicated), Ethanol
CanonicalSMILES: C1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(N=C2N)N
IUPAC Name: (2R,3R,4S,5R)-2-(2,6-diaminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
InChI: InChI=1S/C10H14N6O4/c11-7-4-8(15-10(12)14-7)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H4,11,12,14,15)/t3-,5-,6-,9-/m1/s1
Synonyms: 2,6-Diamino-9-β-D-ribofuranosyl-9H-purine; 2,6-Diaminonebularine; 9-β-Ribosyl-2,6-diaminopurine; 2,6-Diaminopurine Riboside; 2,6-Diaminopurinosine; NSC 7363; 9-β-D-Ribofuranosyl-9H-purine-2,6-diamine; 2,6-Diaminopurine Ribonucleoside; 2,6-Diamino-9-β-D-ribofuranosylpurine

Vidarabine

Description: 9-β-D-Arabinof uranosyladenine is a nucleoside antibiotic produced by Streptomyces antibioticusm and Str. herbaceusm. It has a strong weeding effect on a variety of monocotyledonous and dicotyledonous plants.
CAT: BRP-00205
CAS: 5536-17-4
MF: C10H13N5O4
MF: 267.24
Purity: ≥95%
Appearance: White to Off-white Crystalline Powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20°C under inert atmosphere
Density: 2.08 g/cm3
Melting Point: 260-265°C (dec.)
Boiling Point: 676.3°C at 760 mmHg
Flash Point: 362.8±34.3 °C
InChIKey: OIRDTQYFTABQOQ-UHTZMRCNSA-N
Solubility: Soluble in DMSO (Slightly, Heated), DMF (10 mg/mL), Ethanol (<1 mg/mL at 25°C), Water
CanonicalSMILES: C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N
IUPAC Name: (2R,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
InChI: InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7+,10-/m1/s1
Synonyms: Ara-adenosine; 9-β-D-Arabinofuranosyladenine; 9-(b-D-Arabinofuranosyl)adenine; Adenine arabinoside; Arabinosyladenine; Spongoadenosine; Araadenosine; Arabinosyl adenine; (2R,3S,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; 9-β-D-Arabinofuranosyl-9H-purin-6-amine; Adenine Arabinofuranoside
Related CAS: 24356-66-9 (monohydrate)

2'-O-(2-Methoxyethy)uridine

Description: It is a derivative of uridine that acts as a building block for crosslinking oligonucleotides.
CAT: BRP-00312
CAS: 223777-15-9
MF: C12H18N2O7
MF: 302.28
Purity: ≥95%
Appearance: White to Orange Powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20°C
Density: 1.46±0.1 g/cm3 (Predicted)
InChIKey: XTXNROBDOKPICP-QCNRFFRDSA-N
CanonicalSMILES: COCCOC1C(C(OC1N2C=CC(=O)NC2=O)CO)O
IUPAC Name: 1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)oxolan-2-yl]pyrimidine-2,4-dione
InChI: InChI=1S/C12H18N2O7/c1-19-4-5-20-10-9(17)7(6-15)21-11(10)14-3-2-8(16)13-12(14)18/h2-3,7,9-11,15,17H,4-6H2,1H3,(H,13,16,18)/t7-,9-,10-,11-/m1/s1
Synonyms: Uridine, 2'-O-(2-methoxyethyl)-; 2'-O-Methoxyethyluridine; 1-[(2R,3S,4S,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)tetrahydrofuran-2-yl]pyrimidine-2,4-dione; 2'-O-MOE Uridine; 2'-O-MOE-rU

2'-O-methylinosine

Description: It is a novel nucleoside that is a component of rRNA of Crithidia fasciculata. In addition, it has intrinsic hypotensive activity and is also an apoptosis-inducing nucleoside (AINs).
CAT: BRP-00313
CAS: 3881-21-8
MF: C11H14N4O5
MF: 282.25
Purity: ≥95%
Appearance: White to Off-white Powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at RT
Density: 1.84±0.1 g/cm3 (Predicted)
Melting Point: 153-156°C
Boiling Point: 724.3±60.0°C (Predicted)
Symbol: Im
InChIKey: HPHXOIULGYVAKW-IOSLPCCCSA-N
Solubility: Soluble in Water (Slightly)
CanonicalSMILES: COC1C(C(OC1N2C=NC3=C2N=CNC3=O)CO)O
IUPAC Name: 9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-1H-purin-6-one
InChI: InChI=1S/C11H14N4O5/c1-19-8-7(17)5(2-16)20-11(8)15-4-14-6-9(15)12-3-13-10(6)18/h3-5,7-8,11,16-17H,2H2,1H3,(H,12,13,18)/t5-,7-,8-,11-/m1/s1
Synonyms: Inosine, 2'-O-methyl-; 2'-O-Methyl-inosine; 2'-(o-Methyl)-inosine; 9-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-ol; 2'-(O-Methyl) Inosine
* Only for research. Not suitable for any diagnostic or therapeutic use.
Inquiry Basket